FindTrial
Sign In

Research for objective evaluation of efficacy of anti-Parkinson's drug with repetitive transcranial magneticstimulation in Parkinson's disease

Research for objective evaluation of efficacy of anti-Parkinson's drug with repetitive transcranial magneticstimulation in Parkinson's disease - objective evaluation of efficacy of anti-Parkinson's drug with repetitive transcranial magnetic stimulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000014287
Enrollment
30
Registered
2014-06-18
Start date
2013-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

Patients come two times separated by 1-8weeks. First time, patients before treatment or Off condition and at second time patients are On condition. Before, repetitive magnetic stimulation for 30 min

Sponsors

University of Tokyo Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Parkinson's disease patient from whom we obtained informed consent

Exclusion criteria

Exclusion criteria: In patients with internal metal such as cardiac pace maker, drug delivery pump or DBS, cerebral stroke, brain injury, brain tumor, epilepsy, psychiatric disorder, pregnant females, or those contemplating pregnancy. And people whom the investigators evaluate as approved.

Design outcomes

Primary

MeasureTime frame
Amplitude of the motor evoked potentials(MEP) UPDRS score—

Countries

Japan

Contacts

Public ContactNobuyuki Tanaka

University of Tokyo Hospital Neurology

ntanaka-kob@umin.ac.jp03-3815-5411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026